Evidence map›Paper›PMID 35967437›Full record

ArticleFrontiers in immunology2022

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.

Gai Ge, Zhiya Yang, Dongmei Li, Ning Zhang, Biao Chen, Dongmei Shi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Study on the impact of biofilm formation byFrontiers in cellular and infection microbiology · 2025
    Article
  9. Review
  10. Transcriptomics Reveals Effect ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gai GeInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Zhiya YangLaboratory of Medical Mycology, Jining No.1 People's Hospital, Jining, China.
Dongmei LiDepartment of Microbiology & Immunology, Georgetown University Medical Center, Washington DC, United States.
Ning ZhangLaboratory of Medical Mycology, Jining No.1 People's Hospital, Jining, China.
Biao ChenLaboratory of Medical Mycology, Jining No.1 People's Hospital, Jining, China.
Dongmei ShiLaboratory of Medical Mycology, Jining No.1 People's Hospital, Jining, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNGeorgetown University · USJining First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of the most common gynecological infections, primarily caused by

Indexed as

Candidiasis, VulvovaginalAntifungal AgentsCandidaCandida albicansFemaleHumansImmunityProspective StudiesRecurrenceAntifungal Agentsanti-fungal susceptibilityhost-immune responsesrecurrent vulvovaginal candidiasis (RVVC)T helper cells (Th)vulvovaginal candidiasis (VVC)

Identifiers

PMID35967437
PMCPMC9366074
OpenAlexW4288077486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.